Tate & Lyle PLC
LSE:TATE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
591
807
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Tate & Lyle PLC
Tate & Lyle PLC
Other Liabilities
Tate & Lyle PLC
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tate & Lyle PLC
LSE:TATE
|
Other Liabilities
£113m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-7%
|
|
|
Nomad Foods Ltd
NYSE:NOMD
|
Other Liabilities
€255.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Associated British Foods PLC
LSE:ABF
|
Other Liabilities
£126m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
0%
|
|
|
Premier Foods PLC
LSE:PFD
|
Other Liabilities
£238.7m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Cranswick PLC
LSE:CWK
|
Other Liabilities
£3.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-7%
|
|
|
Bakkavor Group Plc
LSE:BAKK
|
Other Liabilities
£17.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Tate & Lyle PLC
Glance View
Tate & Lyle PLC, with its roots tracing back to the 19th century, has evolved from a traditional sugar refining business into a global leader in the specialty food and beverage ingredient industry. The company, now headquartered in London, has shed much of its historical sugar identity, focusing instead on producing ingredients that enhance texture, sweetness, and nutritional profile in products worldwide. Its strategy pivot reflects a response to modern consumers’ increasing demand for healthier and more sustainable food options. This transformation is evident in its diverse product portfolio, including sweeteners, texturants, and stabilizers, which are pivotal to creating appealing and healthier food experiences without compromising on taste or functionality. The company's business model capitalizes on partnerships with some of the largest food and beverage manufacturers globally. Tate & Lyle makes money by innovating and supplying customized ingredient solutions that align with consumer trends, such as sugar and calorie reduction, fiber fortification, and plant-based alternatives. By focusing on strong research and development, the company stays at the forefront of scientific advancements, integrating cutting-edge food technology with a deep understanding of market demands. The commitment to sustainability and innovation not only fuels its growth but also ensures it contributes to shaping the future of food in a market that is ever more conscious about health and environmental impacts.
See Also
What is Tate & Lyle PLC's Other Liabilities?
Other Liabilities
113m
GBP
Based on the financial report for Mar 31, 2024, Tate & Lyle PLC's Other Liabilities amounts to 113m GBP.
What is Tate & Lyle PLC's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-7%
Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Tate & Lyle PLC have been -13% over the past three years , -11% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet